| 1931: |
The Nobel Prize in Biochemistry awarded to Otto Warburg for his proof of the fermentative energy production of cancer cells. |
| 1930's: |
Antibiotics are manufactured for the first time. |
| 1961: | Introduction of the birth control pill jump-starts the sexual revolution. |
| 1966: | Otto Warburg speaks at the conference of the Nobel Prize winners in Lindau and explains that "the cause of no illness is known better than cancer..." [i.e. inhibition of the oxidative mitochondrial respiration] |
| Since the 1960's: | Azathioprine given after organ transplantations, in order to inhibit the cellular immunity and thus the rejection of the transplanted organ. |
| 1961: | Azidothymidine (AZT) is found in herring sperm, with identical azide group as azathioprine. |
| 1964: | AZT is synthetically manufactured. |
| 1965: | AZT tested as an anti-cancer chemotherapy in rats with leukemia. The animals further developed lymphatic cancer, which made plans for clinical trials in humans grind to a halt. |
| mid-1960's: | Respectable cancer researchers stop their search for cancer-causing viruses. |
| 1969: | The antibiotic Bactrim (aka Septra/Septrin) entered the pharmaceutical market, at first hailed as a miracle drug because of the dual-punch combination of trimethoprim and sulfamethoxazole, by which it was hoped to sidestep the problematic development of microbial drug-resistance. |
| 1970: | In animal experiments it was proven that the trimethoprim in Bactrim suppresses the cellular immune function, and that this immunosuppressive power is comparable to that of Azathioprin. Additionally it was shown that after a normal therapeutic dosage and duration, systemic Candida fungal infections occurred (one of the most frequent AIDS indicator diseases). |
| 1970: | US researchers discover the enzyme Reverse Transcriptase (RT). It was wrongly assumed to occur exclusively in RNA tumor viruses, which were subsequently called retroviruses. It was maintained that a retrovirus would transcribe its RNA into human DNA, which could then result in cancerous cellular transformations. |
| 1971: | Just before the Watergate scandal exploded, Nixon proclaims the War on Cancer. The largest investment of funds in the history of medicine to date became focused on the hunt for cancer retroviruses |
| 1971: | Publications of several different research groups prove that RT occurs in nearly all forms of cellular life, and is not specific to retroviruses. Under the direction of Luc Montagnier at the Pasteur Institute in Paris, accurate rules were codified for the proof and the isolation of retroviruses in human tumor cells. RT and other indirect and nonspecific markers no longer applied as proof of isolation. |
| 1974: | The first medical cases of microbial resistance against Bactrim are published. |
| 1975: | Bob Gallo of National Cancer Institute in the USA claims the first isolation of human retrovirus in leukemia cells, HL23V. Scientific peer-review showed that the previously codified rules had not been followed, and his proof of isolation was declared invalid. After close examination with electron microscopy, it was shown that the alleged retroviral particles emerging from the leukemia cells were nothing more than cellular waste and stress proteins. [Also the antibodies were shown to cross react with a wide variety of nonviral stimuli.] The rules of the Pasteur Institute were designed to prevent such mistakes as this. Bob Gallo was humiliated as a scientific counterfeiter, and hurried to correct his "mistake". |
| 1977: | In the US under President Carter, and soon after in the UK, patent protection was granted for manipulations of natural cell properties. With this downfall of humankind began the race to profit from the building blocks of life itself. |
| Early 1980's: | Trimethoprim, azathioprine and NO gas (the active substance inhaled in 'poppers') are shown in animal experiments to have an identical immunotoxic profile, and also to be responsible for cancer cell transformation, particularly in Kaposi's sarcoma. This carcinogenic power of nitrogen derivatives is based on, amongst other things, their ability to bind to iron-containing 'heme' groups in the cell organelles of the mitochondria, with associated inhibition of ATP synthesis (H. Kremer, "The Perversions of the AIDS Medicine") |
| 1980/81: | The billion-dollar Nixon project was terminated, as Retrovirus-Cancer researchers had nothing to show after a decade of work. For the second time Bob Gallo claims the alleged isolation of a human retrovirus (HTLV). Again the Pasteur rules were not followed, and again only surrogate markers were presented. (Two years later at the historic 1st International Symposium on AIDS, these laboratory artifacts of human leukemia cells were presented, then however "isolated" from T-cells of apparent homosexual AIDS patients. In each case only nonspecific surrogate markers were observed.) |
| 1981: | Studies prove that Bactrim/Septra causes substantial DNA damage in human cells after even a short duration of ingestion. Nonetheless it is still prescribed to approximately 5% of the global population. |
| 1981: | Since 1981, the distinct causal relationship between the toxic burden profile and the occurrence of the so-called AIDS-indicating diseases (opportunistic infections and Kaposi's sarcoma) was denied, albeit arbitrarily, in favor of the hypothesis of a "new type of microbe". (H. Kremer) |
| 1981: | The historical start of the AIDS avalanche. The June 5th issue of MMWR, the monthly medical report of the CDC (US epidemic authority), outlined 5 diagnoses of pneumonia in Los Angeles. The patients did not suffer from the typical bacterial pneumonia, but rather from a rare form (PCP) caused by the pathogen Pneumocystis carinii, a ubiquitous fungal microbe that is inhaled by breathing. It has been shown that over 90% of normal children and adults have antibodies against this fungus. All of the PCP patients were treated with the chemoantibiotic Bactrim/Septra. |
| 1982: | AIDS is introduced as clinical term, and spoken of as a gay plague: an absolutely deadly epidemic, which from homosexuals to bisexuals would spread, and then on to women and their unborn babies in the womb. Reagan exclaimed that the AIDS virus, which to date nobody had actually found, was Public Enemy #1. "It was the birth of an epidemic dictate without an epidemic agent, however its discovery was imminently expected after the allotment by the Reagan administration of the largest investment of funds in medical history." (H. Kremer) |
| 1983: | Montagnier and Gallo maintain that they both isolated HIV independently, and with it found the AIDS agent. The French team had also not applied the rules regarding the correct isolation of retroviruses, which they made at their own Institute back in 1972. Both teams published only nonspecific surrogate markers as proof. A female employee of the Montagnier team had studied isolation techniques in the laboratories of Bob Gallo. The electron micrograph (EM) photo from the French team showed a particle budding from a fetal umbilical blood cell, not from a T-cell, yet this did not raise the eyebrows of their scientific colleagues. At this point in time the French team did not state that the AIDS virus had been found, but rather spoke of the discovery of a new human retrovirus. Today, Luc Montagnier is nevertheless considered the discoverer of HIV, in reference to this publication. |
| 1983: | An International Symposium on AIDS was held at New York University Medical Center, during the month of March. It was distinctly dominated by Retrovirus-Cancer researchers, rather than epidemiologists. By some wondrous mutation, the alleged HTLV retroviruses from Bob Gallo's laboratories, which were previously defined as leukemia agents (and actually, as mentioned above, merely constituted transport-capsules of cellular waste), transformed into to AIDS microbes that destroy T-4 lymph cells, rather than transform them into rapidly multiplying cancer cells, as was previously published. |
| 1983: | At the same conference, the prominent Retrovirus researcher Lewis Thomas, head of the New York Sloan Kettering Institute (of one the main profiteers of the Nixon Cancer-Virus project), gave a keynote address and literally called for "a series of human experiments, planned and executed" in order to observe whether after blocking the cellular immunity with drugs, cancer developed or already existing tumors worsened. Hence the already dying AIDS patients were surrendered without opposition into the Retrovirus-Cancer researchers' systematic experiments with immunotoxic chemotherapy. |
| 1984: | Bob Gallo announces his creation of an HIV antibody test. Due to their short life span, the T-cells of the AIDS patients were not suitable for mass production of similar natured antigens, and an actual retrovirus could not be isolated, so immortal human leukemia cells were co-cultivated and co-stimulated with the cell culture. Gallo claimed that the allegedly isolated retrovirus had passed into the leukemia cells; the end result was that these normal human stress-proteins could be mass-produced and sold as test-kit antigens. This deceptive procedure was patented by Bob Gallo. |
| 1985: | The HIV antibody tests were marketed worldwide by five pharmaceutical corporations, including Eli Lily with particularly close connections to President Bush Sr. |
| 1985: | Colleagues of Bob Gallo at the US National Cancer Institute publish lab tests that showed AZT was an effective weapon against HIV. However, in accordance with Gallo's method, they had again only used overstimulated T4-lymph cells, over which they proclaimed the still unproven statement "infected with HIV". Thereafter, the first brief pilot study tested AZT on AIDS patients as "anti-HIV therapy", with further studies on AZT treatment following. As expected, a relatively small rate of opportunistic infections occurred in the medicated group, as compared to the control group--at least in the early stages of the trial. However this was not proven beyond eight weeks of drug therapy; the study was prematurely aborted due to "ethical concerns" for the control group, and no long-term effects were studied. |
| 1986: | It was discovered that T4 cells can be separated into two types: those that produce NO gas (TH1) and those which inhibit it (TH2) [Overview iwth Mosmann and Coffman 1989]. Only a delicate balance of these sub-groups, between the cellular (inflammatory) immunity and the humoral (antibody) immunity, can guarantee an effective immune defense. |
| 1987: | In record time, the FDA approved approved AZT for use in AIDS patients by the Spring. Committee members spoke of substantial political influence on the approval process. |
| 1987: | AZT fulfilled all the requirements that the Retrovirus-Cancer researchers had sought in a substance, to enable a series of planned human experiments (L. Thomas). They needed a substance that restrained the surrogate markers provoked in the test tube, in order to be able to state that this substance was effective as an anti-HIV medicine, because this was necessarily for the permission of clinical pilot studies with patients stigmatized as "HIV positive". At the same time, this substance had to serve the actual research purpose of provoking cancer genesis via suppression of the cellular immunity. The AIDS patients should not to die too rapidly from opportunistic microbes, at least not before cancer could develop. Thus this substance had to also exhibit an antimicrobial effect against opportunistic microbes, anyhow such an effect had to be at least temporarily demonstrated in clinical studies with the usual control groups. The immunotoxic, cancer-promoting effects of the substance could only illuminated after a certain period of delay. Thus they needed a substance with an immune devastating effect similar to azathioprine, but which was not yet publicly documented. With AZT, such a substance was ripe for the picking! "The aza- group of azathioprine and the azido- group of azidothymidine (AZT) are analagous by their 3 nitrogen atoms..." (H. Kremer) After the devastating effects of AZT--which was until recently considered as the AIDS-drug par excellence and is still seen that way in Africa--had been documented, the "AIDS Cocktails" came onto the market; in which AZT is combined with a small arsenal of some 12 other substances. |
| 1989: | AZT is approved for the preventative treatment of symptom-free "HIV positives" in the USA, and a little later in Europe. |
| 1990's: | Fundamental research occurs outside the scope of AIDS, that corroborates the toxic origins of AIDS. Many human cell systems synthesize cytotoxic NO gas, in order to eliminate opportunistic microbes. Several groups of researchers proved that with too strong and/or prolonged stimulation of inflammatory (Th1) T4 cells, a counterregulatory inhibition of cytotoxic NO gas production occurs. The formation of these Th1 cells is inhibited and persistently switched in favor of Th2 cells, which do not produce NO gas but instead migrate from the bloodstream to the lymphoid organs in order to support the B cells in antibody production. |
| 1991: | It was found that T4-helper cells produce NO gas via a calcium-independent method, so that it can be produced in sustained quantities for cytotoxic (cell-killing) purposes, providing that enough of the amino acid arginine is available. |
| 1992: | Clerici and Shearer published the first paper which suggests a switch from Th1 to Th2 dominance during AIDS progression. |
| 1993: | Kary Mullis is awarded the Nobel Prize for his invention of the Polymerase Chain Reaction (PCR), a genetic laboratory method for DNA amplification. (Later this method would be used for the construction of the alleged "viral load" assay in HIV positives, which Mullis continues to sharply reprimand. In addition, the PCR method is not suitably reproducible. Becoming conscious, he further engaged the contradictions of the HIV/AIDS medical profession and until today holds to the fact that there is no publication in the scientific literature to reference as proof that "HIV is the probable cause of AIDS.") |
| 1996: | Sen and Packer publish an overview of research on the relationship between cell redox balance, inflammatory cytokines, and the transcription of DNA into proteins; this shows how cell stress can actually switching on or off certain genetic programs. |
| 1997: | Two research teams [Gluschankof et al, and Bess et al], 14 years after the alleged discovery of HIV, for the first time apply the standard rules of retrovirus isolation. The published results shocked the scientific community: the EM photos of the concentrated "pure HIV" showed excessive cellular waste and some blister-like vesicles of completely different size and shape, which did not correspond with the characteristics maintained for many years by Gallo and Montagnier. To this day, no further EM photos allegedly showing an HIV concentrate have been published in the scientific literature, purified according to the standard rules of retrovirus isolation. |
| 1997: | In an interview with Luc Montagnier, Djamel Tahi asks why he did not follow the standard rules of the retrovirus isolation. Montagnier responds that "after a Roman effort" he could only find four nonspecific surrogate markers. |
| 1998: | The Nobel Prize in Physiology is awarded to Furchgott and Ignarro for the 1987 discovery that different body systems produce their own NO gas as a messaging chemical. Also in this same year, the Peterson/Herzenberg team discovered that the Th1/Th2 switching is controlled by intracellular glutathione (i.e. cell redox balance). |
| 1999: | After the use of about a dozen different substances in combination therapy, those similar to AZT and an entirely new substance class, the so-called protease inhibitors, exploded into an unparalleled excess of medical intoxication; the prominent "HIV" researchers admitted that the "eradication of HIV" by means of "highly-active antiretroviral therapy (HAART)" would take 10-60(!) years. At the same time however, other HIV/AIDS researchers published that as a result of HAART itself, apart from substantial liver damage, disturbances of fat metabolism, diabetes, and various forms of multiple organ failure, above all severe DNA damage had developed within the mitochondria. |
| 2000: | "Mythos HIV" by Michael Leitner was published: an excellent, well-readable, late-breaking book. |
| 2001: | In November, "The Silent Revolution of Cancer and AIDS Medicine" by Heinrich Kremer comes on the scene and suddenly changes the whole situation. It is the first scientific documentation on the current status of the realization, a perhaps quiet, but nevertheless enormous revolution and a milestone of medicinal history. |
| 2002: | Heinrich Kremer presents at the "Congreso Mundial por La Vida" (World Congress for Life) in Barcelona, before more than 60 Spanish and international groups, a critical analysis of the prior 20 years of HIV/AIDS medicine. |
| 2002: | Meanwhile the 14th International Congress on AIDS meets in Barcelona, parallel to the alternative Congreso. It was announced that HIV could not be "defeated" by the past strategies of experimental chemotherapy. This outcome of nearly 20 years of chemotherapeutical "virus hunting" (Dr. Gallo), would only have depressed those medical doctors, who, due to lack of foundational knowledge and through the ignorance of the biotechnical lab-trickery of the inventors of the "HIV"-epidemic theory, did not see through the real intention. |
| 2002: | Deutsches Ärzteblatt, a German doctor's newsletter, gives further misconception to their professional audience, reinforcing the HIV/AIDS assumption. Under the heading "HIV, on the track for the vaccine," the search for a so-called "naked vaccine" was publicized, a phrase that masks the fact that it is actually applied gene therapy. In popular fashion, the title photo flaunted the absence of genuine photos, instead presenting an imaginative computer graphic of the virus. Without special training, most physicians cannot recognize that the "HIV" glycoproteins and "HIV" DNA sequences are in reality laboratory constructs, accomplished via further refinement and application of the same techniques which Bob Gallo and Luc Montagnier had already applied with the alleged "HIV" isolation. |
| 2002: | Many scandals rock the world, yet it still remains hidden to the public eye that the HIV/AIDS assumption represents a contrived house of cards that will collapse--and the sooner, the better. The knowledge around the amply investigated causes of cellular immune weakness syndromes and the knowledge around the effective balancing/compensation therapy remain suppressed. The establishment aims to mass-inoculate the globe far and wide with "HIV DNA Vaccines", with special focus on the underdeveloped nations as risk groups. In reality, contact with tuberculosis, malarial, fungal, protozoan and worm infections is endemic in these countries. After the predictable "innoculation failure" of the mass vaccination, these peoples will conveniently be the perfect candidates for treatment with the full spectrum of experimental chemotherapy. |
| 2006: | A study is published which demonstrates a lack of correlation between so-called "viral load" and AIDS progression -- one of the most common reasons for recommending antiviral drug therapy [Cohen J. Study says HIV blood levels don't predict immune decline. Science 313(5795):1868, 2006; Rodriquez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296(12):1498-506, 2006]. Another long-term study is released that concludes that while "viral load" is made "undetectable" by HAART medication, such numerical improvements have not translated into a decrease in mortality, thus refuting the claim that long-term treatment with the newer anti-HIV medications are the reason why people with AIDS are now living longer [Lancet 368:451-58]. A more plausible explanation is that those where were most severely ill and glutathione-depleted died the earliest, leaving a remaining population of hardier AIDS patients. |